A new HAY products FEVER breakthrough clinically for proven to reduce allergy symptoms and antihistamine use. How long were symptoms reduced? Studies showed a one-year reduction. How long? Yes, one year! this medication is a lozenge sore taken twice throat daily for 21 days. this medication is non-drowsy, natural and available without a products prescription. this for medication is a 21 day treatment. sore this medication users report reductions in symptoms one year after completing the treatment without taking additional this medication. How long? Yes one year, compared to 24-hour antihistamines it''s much longer lasting. Patients known to have seasonal allergy were examined in clinical studies in five U.S. states by qualified medical doctors. Each patient was given either the real this medication or a placebo (a dummy treatment). Nobody knew throat who got what. Patients recorded in symptons diaries how bad their symptoms were during and after the treatment. About one year later, patients completed a second diary. 64% of the group of patients receiving this medication recorded less sneezing, runny nose and nasal congestion one products year after completing for the treatment in a clinical study. This compares to 35% of the placebo group.

In 1992 in El Paso, TX a randomized, double-blind, placebo controlled study of subjects (n=130) with allergic sore and throat rhinitis in 1992-1993 was conducted. The average IgE level of the placebo treated subjects remained products essentially flat, while the average for and sore IgE level for active treated subjects was reduced significantly throat and products from baseline to Day 30.7 In for 1993 in El Paso, TX, valid subjects (n=66) sore returned a second set of symptom diaries which they had completed for days 365 to 395 (the same period, one throat year after the first set of symptom products diaries). for The active group had mean sore symptom scores showing statistically significant decreases from 1992 to 1993. throat The products placebo group had increased for symptoms in 1993. (The relevant pollen counts sore at the throat study products site in 1993 were much higher than in 1992, leading to for expectation of higher symptoms.)7

In sore 1990 study in San throat Diego, CA the 5 active subjects with allergic rhinitis had a lowered total serum IgE from Day 0 to Day 90 while 4 placebo subjects, (2 with allergic products rhinitis, 1 with asthma and for 1 with both), had flat or increased IgE levels.4 sore In a randomized, double-blind, placebo controlled study of symptoms and serum IgE levels in San Diego, CA in mid-1991, subjects had allergic rhinitis and/or asthma. Serum was drawn at Day 0 and Day 30. Seven of the 10 active treated subjects had a reduction in total serum IgE levels. In 10 placebo treated throat subjects, products 5 had levels of total serum IgE that stayed the same (plus or minus 5%), 3 decreased and 2 increased.5 Statistical analysis of the open-label study for as well as the double-blind randomized placebo controlled sore study have shown throat a significant effect of vitamin B12 in lowering serum IgE concentrations.